Toronto, Ontario--(Newsfile Corp. - August 7, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2024 financial results for the period ended June 30, 2024, on Monday, August 12, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 5:30 pm EST (2:30 pm PST). The call will be hosted by Dr. Alexander Dobranowski, Chief Executive Officer, and Anthony Lam, Chief Financial Officer. Please dial in 10 minutes prior to the start of the call.
Fiscal Second Quarter 2024 Conference Call
Date: Monday, August 12, 2024
Time: 5:30 PM ET / 2:30 PM PT
For attendees who wish to join by webcast, the event can be accessed at: https://edge.media-server.com/mmc/p/ejqqmqy4
Attendees who wish to join by phone must visit the following link and pre-register: https://register.vevent.com/register/BIa66ea4dcfe1b4dd981a3ee71ae03ad54
Instructions for joining by phone:
Dr. Alexander Dobranowski
Chief Executive Officer
HEALWELL AI
About HEALWELL
HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary AI technology and competencies which includes data science, electronic health records and clinical research offerings, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
For more information:
Pardeep Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | C$1.60 |
Daily Change: | -0.08 -4.76 |
Daily Volume: | 637,228 |
Market Cap: | C$218.130M |
November 12, 2024 October 18, 2024 September 25, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB